NEW YORK (GenomeWeb News) – Becton Dickinson today said that its fiscal second-quarter revenues were up almost 4 percent year over year, helped along by a 5 percent increase in the BD Diagnostics segment.

The Franklin Lakes, NJ-based company reported revenues of $2.00 billion for the three months ended March 31, compared to $1.93 billion a year ago, and just beating the consensus Wall Street estimate of $1.99 billion. On a currency-neutral basis, revenues were up a little more than 4 percent, BD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.